Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin.
Loverre A, Ditonno P, Crovace A, Gesualdo L, Ranieri E, Pontrelli P, Stallone G, Infante B, Schena A, Di Paolo S, Capobianco C, Ursi M, Palazzo S, Battaglia M, Selvaggi FP, Schena FP, Grandaliano G. Loverre A, et al. Among authors: ursi m. J Am Soc Nephrol. 2004 Oct;15(10):2675-86. doi: 10.1097/01.ASN.0000139932.00971.E4. J Am Soc Nephrol. 2004. PMID: 15466272
Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy.
Pontrelli P, Rossini M, Infante B, Stallone G, Schena A, Loverre A, Ursi M, Verrienti R, Maiorano A, Zaza G, Ranieri E, Gesualdo L, Ditonno P, Bettocchi C, Schena FP, Grandaliano G. Pontrelli P, et al. Among authors: ursi m. Transplantation. 2008 Jan 15;85(1):125-34. doi: 10.1097/01.tp.0000296831.91303.9a. Transplantation. 2008. PMID: 18192922 Clinical Trial.
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome.
De Matteis S, Del Coco L, De Castro F, Giudetti AM, Casadei B, Iannotta F, De Felice F, Tomassini E, Vaglio F, Naddeo M, Salamon I, Storci G, Laprovitera N, Messelodi D, Bertuccio SN, Tassoni M, Sinigaglia B, Barbato F, Ursi M, Campanini E, Maffini E, Roberto M, Pellegrini C, Dan E, Pirazzini C, Garagnani P, Ferracin M, Zinzani PL, Fanizzi FP, Bonafè M, Bonifazi F. De Matteis S, et al. Among authors: ursi m. Haematologica. 2024 Dec 19. doi: 10.3324/haematol.2024.285154. Online ahead of print. Haematologica. 2024. PMID: 39704157 Free article.
Epigenetic age acceleration in hematopoietic stem cell transplantation.
Ursi M, Kwiatkowska KM, Pirazzini C, Storci G, Messelodi D, Bertuccio SN, De Matteis S, Iannotta F, Tomassini E, Roberto M, Naddeo M, Laprovitera N, Salamon I, Sinigaglia B, Dan E, De Felice F, Barbato F, Maffini E, Falcioni S, Arpinati M, Ferracin M, Bonafè M, Garagnani P, Bonifazi F. Ursi M, et al. Haematologica. 2024 Oct 3. doi: 10.3324/haematol.2024.285291. Online ahead of print. Haematologica. 2024. PMID: 39363850 Free article.
Efficacy of CARVYKTI in CARTITUDE-4 versus other conventional treatment regimens for lenalidomide-refractory multiple myeloma using inverse probability of treatment weighting.
Alsdorf W, Diels J, Ghilotti F, Mendes J, Hernando T, Cost P, Schecter JM, Lendvai N, Patel N, Triguero A, Ursi M. Alsdorf W, et al. Among authors: ursi m. J Comp Eff Res. 2024 Sep;13(9):e240080. doi: 10.57264/cer-2024-0080. Epub 2024 Aug 20. J Comp Eff Res. 2024. PMID: 39162049 Free PMC article. Clinical Trial.
52 results